Krishna Institute of Medical Sciences Limited will host an analyst and institutional investor meeting on September 21, 2026. The event is scheduled as part of the J.P. Morgan India Conference in Mumbai.

The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is classified as a group session.

Meeting Details

The engagement aims to provide updates to investors without sharing unpublished price-sensitive information. The schedule remains subject to change based on exigencies.

Nagajanthi J.R., Company Secretary and Compliance Officer, signed the disclosure filed with the Bombay Stock Exchange and National Stock Exchange.

Krishna Institute of Medical Sciences Ltd has entered into an operations and management agreement with Sarvottam Health Care Private Limited to manage a healthcare facility in Kakinada, Andhra Pradesh.

Krishna Institute of Medical Sciences signed the deal on September 10, 2026, securing exclusive rights to operate and control the hospital for an initial term of five years. The agreement includes an option to extend for a further five-year period.

Deal Structure and Financial Terms

Under the terms of the agreement, Krishna Institute of Medical Sciences will receive a revenue fee of 9% of the total net revenue generated by the hospital. The contract defines net revenue as gross revenue billed to patients minus any concessions or discounts offered.

The arrangement is structured as a domestic operation with no share exchange or joint venture ratio involved. Krishna Institute of Medical Sciences will hold exclusive supervision and control over the hospital's operations, assuming sole responsibility for its management.

Facility Details and Strategic Rationale

Sarvottam Health Care Private Limited operates the "Trust Multi Speciality Hospital," which commenced operations in 2010 with 50 beds. The facility expanded significantly in 2021 with the inauguration of a state-of-the-art G+7 structure.

The company noted that this partnership enhances its presence in Andhra Pradesh, a region identified as having significant growth potential. Sarvottam Health Care benefits from Krishna Institute of Medical Sciences' operational expertise and medical supervision capabilities.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the transaction does not fall within related party transactions, and neither the promoters nor group companies have any interest in Sarvottam Health Care Private Limited.

Source: